Onward Medical N.V. Logo

Onward Medical N.V.

Develops spinal stimulation therapies to restore movement for people with spinal cord injury.

ONWD | AS

Overview

Corporate Details

ISIN(s):
NL0015000HT4
LEI:
9845007A2CC4C8BFSB80
Country:
Netherlands
Address:
Schimmelt 2, 5611ZX Eindhoven
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

Onward Medical N.V. is a medical technology company developing therapies to restore movement, function, and independence for people with spinal cord injury (SCI). The company's core technology is ARC Therapy, a platform that uses targeted, programmed electrical stimulation of the spinal cord. Its portfolio includes the ARCEX System, a non-invasive, external device cleared by the FDA for use in the United States to improve hand and arm function in individuals with SCI. Onward is also advancing investigational implantable systems, including ARCIM and ARCBCI, which may be combined with a brain-computer interface (BCI). The company's research and development is supported by multiple FDA Breakthrough Device Designations and a portfolio of nearly 400 issued or pending patents.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-28 17:45
Share Issue/Capital Change
ONWARD Medical Publishes Closing of Bookbuild Offering
English 170.7 KB
2025-10-17 07:30
Share Issue/Capital Change
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
English 199.1 KB
2025-10-13 07:30
Earnings Release
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating AR…
English 181.2 KB
2025-09-18 07:30
Regulatory Filings
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blo…
English 205.3 KB
2025-09-02 07:42
Interim / Quarterly Report
ONWARD Medical N.V., Halfjaarlijkse financiële verslaggeving
English 8.8 MB
2025-09-02 07:30
Earnings Release
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the Fi…
English 208.1 KB
2025-08-18 18:30
Regulatory Filings
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Stu…
English 208.3 KB
2025-07-07 11:20
Board/Management Information
ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison…
English 154.2 KB
2025-06-12 07:52
AGM Information
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
English 138.1 KB
2025-06-11 19:00
AGM Information
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
English 138.1 KB
2025-05-01 06:28
Pre-Annual General Meeting Information
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders a…
English 115.4 KB
2025-04-30 17:30
Pre-Annual General Meeting Information
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders a…
English 115.4 KB
2025-04-28 08:30
Report Publication Announcement
ONWARD Medical Announces Release of 2024 Annual Report
English 104.0 KB
2025-04-28 08:09
Annual Report (ESEF)
ONWARD Medical N.V., Jaarlijkse financiële verslaggeving
English 8.0 MB
2025-04-01 07:30
Earnings Release
ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice…
French 291.0 KB

Automate Your Workflow. Get a real-time feed of all Onward Medical N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Onward Medical N.V.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Onward Medical N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-01-19 G.R. Courtine Non-Executive member Other 451,822 N/A
2023-01-03 D.L. Marver Non-Executive member Other 385,000 N/A
2022-12-23 F.A. Colen Non-Executive member Other 47,740 N/A
2022-11-18 D.L. Marver Non-Executive member Other 954,814 N/A
2022-09-29 V.E. Riefberg Non-Executive member Other 16,000 N/A
2021-12-15 J.K. Ohrstrom Non-Executive member Other 38,000 N/A
2021-10-22 D.L. Marver Non-Executive member Other 6,765 N/A

Peer Companies

Acarix Logo
AI-powered acoustic system for rapid, non-invasive rule-out of Coronary Artery Disease.
Sweden
ACARIX
ACCURAY INC Logo
Develops robotic and image-guided radiation therapy systems for cancer treatment.
United States of America
ARAY
Develops a pain-free breath device to measure blood glucose for diabetes management.
Poland
AME
Agfa-Gevaert NV Logo
Develops imaging systems & IT solutions for printing, healthcare, and industrial applications.
Belgium
AGFB
Alcon AG Logo
Global leader in eye care, offering surgical equipment, contact lenses, and ocular health products.
Switzerland
ALC
Arcoma AB Logo
Develops and manufactures advanced digital X-ray and radiology solutions for global healthcare.
Sweden
ARCOMA
ASTERASYS Co., Ltd. Logo
Develops HIFU and body analysis devices for the global aesthetic and healthcare market.
South Korea
450950
Baird Medical Investment Holdings Ltd Logo
Develops microwave ablation devices for minimally invasive treatment of benign and malignant tumors.
United States of America
BDMD
Beta Bionics, Inc. Logo
Develops an automated insulin delivery system to simplify management of type 1 diabetes.
United States of America
BBNX
BIO PROTECH INC. Logo
Manufactures medical devices and consumables for surgery, cardiology, neurology & pain management.
South Korea
199290

Talk to a Data Expert

Have a question? We'll get back to you promptly.